Forus raises $150M at $3B valuation for AI drug access platform
Healthcare automation startup Forus raised $150 million in a Series C round led by Bain Capital Ventures, tripling its valuation to $3 billion in approximately four months. The company uses AI to accelerate patient access to specialty medicines.